July 10, 2012 - 06:07 pm
Posted in Featured
0 Comments
In an effort to provide you with timely market feedback from ASCO 2012, OBR and MDOutlook Oncology Intelligence are pleased to share results from MDOutlook’s 5th Annual post-ASCO survey fielded among its global network of more than 62,000 cancer providers.
This forth Quick-Poll to be published in the OBR blog explores Prostate Cancer. Take a look back at our previous blog postings to see QuickPolls on other tumor types as well.
Key Conclusions:
Key Conclusions:
2) Abiraterone Acetate is Expected to be More Clinically Important for Chemotherapy-Naïve mCRPC Patients than in the Neoadjuvant Setting
Key Conclusions:
Key Conclusions:
Key Conclusions:
Key Conclusions:
Quick polls are a fast way of measuring expected acceptance of clinical data post major medical meetings, and perhaps can be used to make some assumptions about adoption amongst providers. In today’s information hungry environment, the speed at which these polls can be conducted and analyzed can be advantageous for market planning and “pressure testing” acceptance of data amongst key stakeholders.
Submitted by Jan Heybroek, President and Robert Stephan, Sr. Director Medical Services, The Arcas Group
July 03, 2012 - 12:07 am
Posted in Featured
0 Comments
In an effort to provide you with timely market feedback from ASCO 2012, OBR and MDOutlook Oncology Intelligence are pleased to share results from MDOutlook’s 5th Annual post-ASCO survey fielded among its global network of more than 62,000 cancer providers.
This third Quick-Poll to be published in the OBR blog explores Colorectal Cancer (CRC) & Hepatocellular Carcinoma (HCC). Stay tuned to our blog in the coming weeks as we publish QuickPolls on the other tumor types as well.
Key Conclusions:
Key Conclusions:
Key Conclusions:
Key Conclusions:
Quick polls are a fast way of measuring expected acceptance of clinical data post major medical meetings, and perhaps can be used to make some assumptions about adoption amongst providers. In today’s information hungry environment, the speed at which these polls can be conducted and analyzed can be advantageous for market planning and “pressure testing” acceptance of data amongst key stakeholders.
Submitted by Jan Heybroek, President and Robert Stephan, Sr. Director Medical Services, The Arcas Group